The company’s goal is to increase resiliency of the U.S. medical device supply chain
Apr 1, 2021
TUCSON, Ariz.—The medical technology company BD (Becton, Dickinson and Company) reported that it will invest $65 million to construct a state-of-the-art facility in Tucson, Arizona that will be a hub for the company’s supply chain and serve as a final-stage manufacturing and sterilization center.
The new 120,000-square-foot facility will be built on approximately 32 acres at the northeast corner of Valencia and Kolb Road and is planned to be operational in mid-2022. BD plans to add approximately 40 new jobs, including engineers, scientists, quality control specialists, and other skilled talent. Sun Corridor, Inc. projects that BD’s investment will have a $122 million economic impact over the next 10 years, according to a release from BD.
As part of the company’s response to COVID-19 and commitment to public health, BD is investing significantly in its in-house capacity for manufacturing and sterilization. The new facility will advance BD’s goals of improved overall operational efficiency, customer service levels, and supply chain resilience, the company said in the release.
BD said in the release that the project will become an integral part of the U.S. medical device supply chain. It will expand the footprint BD already has in Arizona, which includes a $1 billion BD Peripheral Intervention business unit headquartered in Tempe.
“Tucson is the ideal location for critical infrastructure and was selected after a careful review of a number of alternative locations in the southwestern U.S. and Mexico,” said Alexandre Conroy, executive vice president, integrated supply chain for BD, in the release. “Arizona’s favorable business climate, the strength of its workforce, and Tucson’s centrality to other parts of BD’s supply chain were key factors in the decision.”
BD said that it operates more than 90 medical device and health care technology manufacturing and sterilization facilities across the globe and has a track record of sustainable operations. The new facility will be one of the first in the world with an original design that will meet or exceed the most stringent environmental guidelines and serve as a model for other sites worldwide, according to the release.
Tucson is centrally located between eight of BD’s U.S. major manufacturing plants and three distribution centers. BD said that it selected this specific site in Ward 4 because it sits within compatible existing and planned industrial areas.
“We’re thrilled to welcome BD to Tucson,” said Tucson Mayor Regina Romero, in the release. “Tucson’s strategic location, coupled with our tech companies, university, workforce, and proximity to Mexico, were key strengths that led to this successful outcome for our region.”
Joe Snell, president and CEO, Sun Corridor Inc., stated, “We were tenacious in our efforts to win this project. BD joins Roche Tissue Diagnostics, Accelerate Diagnostics, HTG Molecular, and other companies here doing cutting-edge work to help solve our country’s greatest challenges.”
Judy Rich, president and CEO, TMC HealthCare and chair of the board, Sun Corridor Inc., said in the release that BD “has a long history of commitment to public health and is deeply involved in many aspects of the nation’s COVID response. For this global powerhouse to choose Tucson for its new state-of-the-art manufacturing and sterilization facility is big news. We thank BD for its significant investment in Southern Arizona.”
Project partners include the Arizona Commerce Authority, City of Tucson, Pima County, Pima Community College, Tucson Electric Power, Southwest Gas, Lumen, Primus Builders, Perry Engineering, Azbil Telstar, Lesni A/S, Advanced Air Technologies, Inc., Cushman & Wakefield/PICOR, and JLL (Jones Lang LaSalle).
“Tucson’s economic transformation is a national success story, and BD is excited to be part of it,” Conroy continued. “We have worked closely with Mayor Romero and the city government to identify this site and ensure its compatibility with our planned work and with the city’s vision for the area. Tucson will become a crucial part of the manufacturing of medical devices and the resilience needed within our health care supply chain.”